Importantly, alisertib treatment significantly inhibited the formation of metastatic nodules in the lung, and up-regulated E-cadherin and inhibited N-cadherin expression (Fig. S8), again confirming that inhibition of AURKA could significantly reverse the effect of TIALD knockdown on promoting HCC metastasis. This evidence concerns the gene TIALD and hepatocellular carcinoma.